A Randomized Controlled Trial of Epidermal Growth Factor Ointment for Treating Epidermal Growth Factor Receptor Inhibitor‐Induced Skin Toxicities

BACKGROUND: The efficacy of epidermal growth factor (EGF) receptor (EGFR) inhibitors in patients with non‐small cell lung cancer (NSCLC), pancreatic cancer (PC), or colorectal cancer (CRC) has been demonstrated. However, dermatological reactions to these inhibitors can cause significant physical and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Kim, Young Saing, Ji, Jun Ho, Oh, Sung Yong, Lee, Suee, Huh, Seok Jae, Lee, Ji Hyun, Song, Ki‐Hoon, Son, Choon Hee, Roh, Mee Sook, Lee, Gyeong Won, Lee, Jeeyun, Kim, Seung Tae, Kim, Chan Kyu, Jang, Joung Soon, Hwang, In Gyu, Ahn, Hee Kyung, Park, Lee Chun, Oh, So Yeon, Kim, Seong‐Geun, Lee, Sang‐Cheol, Lim, Do‐Hyoung, Lee, Soon Il, Kang, Jung Hun
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2019
Assuntos:
Symptom Management and Supportive Care
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6964120/
https://ncbi.nlm.nih.gov/pubmed/31492766
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0221
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados